首页> 外文期刊>Psychiatry Investigation >Changes in Behaviour Symptoms of Patients with Attention Deficit/Hyperactivity Disorder during Treatment: Observation from Different Informants
【24h】

Changes in Behaviour Symptoms of Patients with Attention Deficit/Hyperactivity Disorder during Treatment: Observation from Different Informants

机译:注意缺陷/多动障碍患者在治疗期间的行为症状变化:观察不同的信息提供者

获取原文
           

摘要

Objective The aim of this study was to determine changes in behaviour among patients with attention deficit/hyperactivity disorder (ADHD) by different informants during treatment in the clinical setting. Methods Seventy-nine patients with ADHD were recruited. They completed 12-months of treatment with oral short-acting methylphenidate, two-to-three times per day, at a dose of 0.3-1.0 mg/kg. Among the 79 patients (mean age, 9.1±1.9 years), 39 were classified as the ADHD-C/H type (hyperactive-impulsive type and combined type) and 40 as the ADHD-I type (inattentive type). At baseline, and after 12 months, their behaviour was assessed using the Child Behaviour Checklist (CBCL), Teacher's Report Form (TRF), ADHD Rating Scale (ADHD-RS), and Clinical Global Impression-Severity (CGI-S). Results Patients classified as the ADHD-C/H type had higher scores on three CBCL subscales, on the ADHD-RS and CGI-S compared to the ADHD-I type patients. After 12-months of treatment, for all patients, there were significant improvements in the four subscales of the TRF as well as the ADHD-RS and CGI-S scores, but not on the CBCL. In addition, the patients with the ADHD-C/H type had greater improvements on the four subscales of the TRF after treatment. However, there were no differences noted on the CBCL, ADHD-RS and CGI-S. Conclusion The results of this study showed that during treatment, in the clinical setting, there are different assessments of behaviour symptoms, associated with ADHD, reported by different informants. Assessments of behaviour profiles from multiple informants are crucial for establishing a fuller picture of patients with ADHD.
机译:目的本研究的目的是确定临床环境中治疗过程中不同知情者在注意缺陷/多动障碍(ADHD)患者中的行为变化。方法招募79例ADHD患者。他们以0.3-1.0 mg / kg的剂量每天口服2到3次口服速效哌醋甲酯完成12个月的治疗。在这79例患者(平均年龄为9.1±1.9岁)中,有39例被分类为ADHD-C / H型(多动冲动型和合并型),另外40例被分类为ADHD-I型(注意力不集中型)。在基线和12个月后,使用儿童行为清单(CBCL),教师报告表(TRF),ADHD评分量表(ADHD-RS)和临床总体印象严重度(CGI-S)评估他们的行为。结果与ADHD-I型患者相比,被分类为ADHD-C / H型患者的ADHD-RS和CGI-S在三个CBCL分量表上得分更高。在治疗12个月后,对于所有患者,TRF的四个子量表以及ADHD-RS和CGI-S得分都有显着改善,但CBCL却没有。此外,ADHD-C / H型患者在治疗后TRF的四个子量表上有更大的改善。但是,在CBCL,ADHD-RS和CGI-S上没有发现差异。结论这项研究的结果表明,在治疗期间,在临床环境中,由不同的信息提供者报告了与ADHD相关的行为症状评估。对多位线人的行为概况进行评估对于建立多动症患者的全貌至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号